Table 5.
WPC Index
| FS Method | NLSVR | PCR | NLSVR NSCLC-AD | p NSCLC-AD |
|---|---|---|---|---|
| NO FS | 0.581 | 0.578 | 0.528 | 0.009 |
| DEG | 0.582 | 0.579 | 0.535 | 0.001 |
| CTR1 | 0.581 | 0.576 | 0.519 | 0.056 |
| CTR2 | 0.576 | 0.559 | 0.508 | 0.248 |
| MRMR | 0.579 | 0.575 | NA | NA |
| BS | 0.58 | 0.576 | NA | NA |
| BC | 0.575 | 0.571 | NA | NA |
| Hist | 0.552 | 0.552 | NA | NA |
| Random Control | NA | 0.498 | NA | NA |
WPC Index for NLSVR and PCR models as well as values for non small cell lung cancer adenocarcinoma (NSCLC-AD) in select drugs. The-value for NSCLC-AD was calculated by 3000 random permutations of the test data to construct a null distribution. For example, there is a .01% chance of obtaining a higher WPC score randomly for NLSVR DEG models on NSCLC-AD. Note that a wpc score cannot be calculated for the random control for NLSVR due to a variance of 0 which results in division by 0 incalculated wpc scores